Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Tai chi and checkups may boost hormone therapy adherence in seniors

NCT ID NCT02216162

Disease control Sponsor: Hospices Civils de Lyon Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a program of regular geriatric checkups, nutrition support, and weekly Tai Chi classes could help women over 70 with breast cancer stay on their hormone therapy. The 12 participants had their blood tested over 3 years to see if they were taking their medication correctly. The goal was to reduce side effects like joint pain and improve quality of life, making it easier to complete the full 5-year treatment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
adapted physical activity (Tai Chi) and enhanced geriatric follow-up
What this could lead to
If successful, this approach could help older breast cancer patients stay on their hormone therapy longer by managing side effects like joint pain.
What could go wrong
This is a very small pilot study (12 participants) with no control group, so results may not apply widely. The intervention is supportive, not a treatment for cancer itself.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

12 people

The number who actually took part.

Started

Apr 2014

Finished

Feb 2019

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

70 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ≥ 70 years old * Non metastatic breast cancer, with or without node metastases * Hormone Receptor (HR) positive breast cancer patients * Women with breast adenocarcinoma, confirmed by a pathologist and who underwent surgery or radiotherapy * Introduce an hormonal therapy during 5 years * Life expectancy \> 6 months (at the discretion of the investigator) * Covered by a Health System where applicable, and/or in compliance with the recommendations of the national laws in force relating to biomedical research * Patient must be available for follow-up * Having given written informed consent prior to any procedure related to the study Exclusion Criteria: * No other primary malignant tumor \< 5-years old except cured in situ cancer of the cervix, in situ urothelial cancer, or basocellular cancer * Patient with an experimental treatment in the 30 days prior to the enrollment * Evidence of metastatic disease * Not under any administrative or legal supervision

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm Patient Compliance

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Breast cancer

Contacts and locations

Locations

  • Claire Falandry

    Lyon, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.